Esperion Therapeutics Inc. has nominated ESP-2001 as a preclinical development candidate for the treatment of primary ...
Northrop Grumman Corporation NOC is scheduled to report third-quarter 2025 results on Oct. 21, before market open. The ...
Lockheed Martin Corporation LMT is scheduled to release third-quarter 2025 results on Oct. 21, before market open. The ...